About 1 result found for searched term "Garivulimab" (0.149 seconds)
Cat.No. | Name | Target |
---|---|---|
M25083 | Garivulimab | PD-1/PD-L1 |
BGB-A333 | ||
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction of PD-L1 and PD-1. Garivulimab has antitumor activity. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.